Mission: Our mission is to build a global, patient-forward, cancer learning network where peer and professional navigators guide patients through the innovations of today’s molecular medicine.
View our program brochure here
First Patient Dosed in Trial of [212Pb]VMT01 for Metastatic Melanoma
What Patients With Kidney Cancer Need to Know From ASCO GU
Research Shines Light on Disparities Across Breast Cancer Care
FDA Approves Imfinzi Therapy in Muscle Invasive Bladder Cancer